GCAN Stock Chart & Stats
0.19
0.00(0.00%)
―
--
Day’s Range― - ―
52-Week Range0.04 - 0.45
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
$183.37K
Enterprise Value405.12K
Total Cash (Recent Filing)$1.44K
Total Debt (Recent Filing)$268.60K
Price to Earnings (P/E)1940.5
Beta-1.35
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding944,935
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-83.43
Price to Sales (P/S)0.00
P/FCF Ratio-1.03K
Enterprise Value/Market Cap2.21
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit971.52
Enterprise Value/Ebitda-1.55
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Greater Cannabis News
GCAN FAQ
What was Greater Cannabis’s price range in the past 12 months?
Greater Cannabis lowest stock price was 0.04 and its highest was 0.45 in the past 12 months.
What is Greater Cannabis’s market cap?
Greater Cannabis’s market cap is $183.37K.
When is Greater Cannabis’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Greater Cannabis’s earnings last quarter?
Currently, no data Available
Is Greater Cannabis overvalued?
According to Wall Street analysts Greater Cannabis’s price is currently Undervalued.
Does Greater Cannabis pay dividends?
Greater Cannabis does not currently pay dividends.
What is Greater Cannabis’s EPS estimate?
Greater Cannabis’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Greater Cannabis have?
Greater Cannabis has 944,935 shares outstanding.
What happened to Greater Cannabis’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Greater Cannabis?
Currently, no hedge funds are holding shares in GCAN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Greater Cannabis
The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics. It offers an oral transmucosal patch platform, which provides loaded actives absorbed by the buccal mucosa into the body. The company has a license agreement with Shaare Zedek Scientific Ltd. that focuses on treatment of autism, schizophrenia, Parkinson’s disease, Alzheimer’s disease, and other neuropsychiatric disorders. The company was founded in 2014 and is based in Baltimore, Maryland.